Astramedix Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-07-2024
- Paid Up Capital ₹ 0.50 M
as on 06-07-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 64.48%
(FY 2021)
- Profit 1115.29%
(FY 2021)
- Ebitda -11.14%
(FY 2021)
- Net Worth 13.86%
(FY 2021)
- Total Assets 17.37%
(FY 2021)
About Astramedix Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Vinod Pillai and Jolly Pillai serve as directors at the Company.
- CIN/LLPIN
U25111MH2018PTC307861
- Company No.
307861
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Astramedix Lifesciences Private Limited offer?
Astramedix Lifesciences Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Anaesthesia Machine, Ventilator Parts & Consumables, Oxygen Mask, CPAP, BiPAP Machine & Accessories, Respiratory Therapy Equipment, Flanges & Flanged Fittings, Plastic Flanges, Infusion Syringes & Supplies, Medical Tubes.
Who are the key members and board of directors at Astramedix Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Pillai  | Additional Director | 07-Jul-2021 | Current |
| Jolly Pillai | Director | 11-Apr-2018 | Current |
Financial Performance and Corporate Structure Insights of Astramedix Lifesciences.
Astramedix Lifesciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 64.48% increase. The company also saw a substantial improvement in profitability, with a 1115.29% increase in profit. The company's net worth Soared by an impressive increase of 13.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Astramedix Lifesciences?
In 2020, Astramedix Lifesciences had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Astramedix Lifesciences?
Unlock and access historical data on people associated with Astramedix Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Astramedix Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astramedix Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
